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Secretagogin (SCGN) which acts as a calcium signaling sensor, has previously been
shown to be expressed by a substantial population of cortical GABAergic neurons at
mid-gestation in humans but not in mice. The present study traced SCGN expression in
cortical GABAergic neurons in human fetal forebrain from earlier stages than previously
studied. Multiple potential origins of SCGN-expressing neurons were identified in the
caudal ganglionic eminence (CGE) lateral ganglionic eminence (LGE) septum and
preoptic area; these cells largely co-expressed SP8 but not the medial ganglionic
eminence marker LHX6. They followed various migration routes to reach their target
regions in the neocortex, insular and olfactory cortex (OC) and olfactory bulbs. A robust
increase in the number of SCGN-expressing GABAergic cortical neurons was observed
in the midgestational period; 58% of DLX2+ neurons expressed SCGN in the cortical wall
at 19 post-conceptional weeks (PCW), a higher proportion than expressed calretinin, a
marker for GABAergic neurons of LGE/CGE origin. Furthermore, although most SCGN+
neurons co-expressed calretinin in the cortical plate (CP) and deeper layers, in the
marginal zone (MZ) SCGN+ and calretinin+ cells formed separate populations. In the
adult mouse, it has previously been shown that in the rostral migratory stream (RMS),
SCGN, annexin V (ANXA5), and matrix metalloprotease 2 (MMP2) are co-expressed
forming a functioning complex that exocytoses MMP2 in response to calcium. In the
present study, ANXA5 showed widespread expression throughout the cortical wall,
although MMP2 expression was very largely limited to the CP. We found co-expression
of these proteins in some SCGN+ neurons in the subventricular zones (SVZ) suggesting
a limited role for these cells in remodeling the extracellular matrix, perhaps during
cell migration.
Keywords: annexin V, cerebral cortex, ganglionic eminences, inhibitory interneurons, matrix metalloprotease 2,
preoptic area, secretagogin, septum
Abbreviations: COUPTF-II, chicken ovalbumin upstream promoter transcription factor 2; DLX2, distal-less homeobox 2;
GAD 67, glutamate decarboxylase isoform molecular weight 67 kD; GABA, gamma-aminobutyric acid; LHX6, LIM/homeobox
protein 6; NKX2.1, NK2 homeobox 1; RNAseq, sequencing of total RNA species isolated from tissues; RPKM, Reads Per
Kilobase of the transcript, per Million, mapped reads; SNAP25, synaptosome associated protein 25 kD; SP8, specificity
protein 8.
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INTRODUCTION
Secretagogin is an EF-hand calcium-binding protein similar in
sequence and structure to calbindin (CalB) and calretinin (CalR)
however these proteins are likely to have different functions
(Schwaller, 2009). Secretagogin (SCGN) has a very high affinity
for Ca2+ and acts as a calcium sensor (Rogstam et al., 2007;
Khandewal et al., 2017) whereas CalB and CalR have moderate to
high affinity and could act as both sensors and buffers (Schmidt,
2012; Schwaller, 2014). SCGN is known to have an important
role in exocytosis in certain cells, for instance, pancreatic beta
cells and neuroendocrine cells of the hypothalamus (Wagner
et al., 2000; Romanov et al., 2015; Yang et al., 2016). Pancreatic
beta cells are known to co-express isoforms of glutamate
decarboxylase (GAD) the GABA synthesizing enzyme (Kim
et al., 1993). In the hypothalamus, SCGN is co-expressed by a
subset of GABAergic parvocellular neurons but not exclusively
by this subset (Romanov et al., 2015). A ground-breaking
study (Raju et al., 2018) demonstrated that expression of
SCGN by cortical GABAergic neurons during development
originating from the caudal and lateral ganglionic eminence
(CGE and LGEs) at mid-gestation is a feature of human but not
the mouse. Furthermore, SCGN expression is developmentally
regulated and peaks before birth (Raju et al., 2018) with a
very low density of interneuron-like SCGN+ cells detected
in the neocortex of adult human post mortem brain by
immunohistochemistry (Gartner et al., 2001; Tapia-González
et al., 2020). However, a much higher density of both cell body
and neuropil staining is observed in the human hippocampal
and parahippocampal formations (Attems et al., 2007; Tapia-
González et al., 2020).
It has been postulated that SCGN expression may contribute
to increased dendritic complexity exhibited by interneurons
of CGE origin in primates, and evidence to support this
was provided by forcing expression of SCGN in developing
mouse cortical interneurons and demonstrating increased
dendritic complexity in such neurons compared to controls
(Raju et al., 2018). SCGN interacts with the SNARE (soluble
N-ethylmaleimide-sensitive fusion attachment protein receptor)
protein SNAP25 in response to binding calcium (Rogstam
et al., 2007). Exocytosis is the mechanism by which a new cell
membrane is added to neurite growth cones (Tsaneva-Atanasova
et al., 2009; Zylbersztejn and Galli, 2011) involving synapse
related SNARE proteins (Kunwar et al., 2011) thus it seems
entirely plausible that SCGN could play a role in regulating
neurite outgrowth.
In addition to neurite outgrowth, cell migration is another
developmental process that could be under differential control
between species. The developing human forebrain appears to
manifest more routes of migration for interneuron precursors
from ventral to dorsal telencephalon than the rodent, perhaps
reflecting the larger cell numbers and greater distances involved
(Clowry et al., 2018; Molnár et al., 2019). It has been shown
in the rostral migratory stream (RMS) a pathway guiding
neuroblast migration from subventricular zone to olfactory
bulb throughout life (Lois and Alvarez-Buylla, 1994) there
is a scaffold of SCGN expressing neurons that exocytose
matrix metalloprotease 2 (MMP2) via activation of SCGN and
recruitment of Annexin V (ANXA5). Furthermore, restructuring
of the extracellular matrix by MMP2 promotes neuroblast
migration (Hanics et al., 2017). Recent research has shown
that in the early postnatal forebrain, nearby to the RMS, lies
a dorsal migratory stream that supplies GABAergic neurons to
late-developing prefrontal cortical areas in both humans (up to
5 months postnatally; Sanai et al., 2011; Paredes et al., 2016)
and ferret (up to 90 days postnatally; Ellis et al., 2019). A large
proportion of these interneurons express SCGN (Raju et al., 2018;
Ellis et al., 2019).
Our previous study demonstrated that SCGN expression
is not confined to GABAergic neurons in the developing
human forebrain but is also, for instance, a transient feature
(7–10 post-conceptional weeks) of human thalamic projection
neuron development (Alzu’bi et al., 2019). We also noticed
that SCGN is expressed by various groups of cells in the
ventral telencephalon at this stage. The present study explores
further these previously unreported early expression patterns
of SCGN, revealing multiple origins for SCGN+ GABAergic
neurons and tracing multiple migratory pathways to the cerebral
cortex and olfactory bulbs. Also, we explored the co-expression
of SCGN with annexin V (ANXA5) or matrix metalloprotease
(MMP2) to understand better the potential functional roles
of SCGN.
MATERIALS AND METHODS
Human Tissue
Human fetal tissue from terminated pregnancies was obtained
from the joint MRC/Wellcome Trust-funded Human
Developmental Biology Resource (HDBR1; Gerrelli et al.,
2015). All tissue was collected with appropriate maternal
consent and approval from the Newcastle and North Tyneside
NHS Health Authority Joint Ethics Committee. Fetal samples
ranging in age from 6.5 to 19 post-conceptional weeks (PCW)
were used; 2 at 6.5 PCW, 2 at 7.5 PCW, 2 at 8 PCW, 2 at
10 PCW, 3 at 12 PCW and 2 at 19 PCW. Ages were estimated
from images of Carnegie stages provided by HDBR (up to
8 PCW) and foot and heel to knee length measurements
according to Hern (1984) for later developmental stages.
For immunostaining, brains were isolated and fixed for at
least 24 h at 4◦C in 4% paraformaldehyde (Sigma–Aldrich)
dissolved in 0.1 M phosphate-buffered saline (PBS). Once
fixed, whole or half brains (divided sagittally) were dehydrated
in a series of graded ethanols before embedding in paraffin.
Brain samples were cut at 8-µm section thickness in three
different planes; horizontal, sagittal, and coronal, and mounted
on slides.
Immunohistochemistry
This was carried out on paraffin sections according to previously
described protocols (Alzu’bi et al., 2017). Antigen retrieval
involved boiling in 10 mM citrate buffer pH6 for 10 min.
Sections were incubated with primary antibody [diluted in10%
1https://www.hdbr.org
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normal blocking serum in Tris-buffered saline (TBS) pH 7.6]
overnight at 4◦C. Details of primary antibodies are found
in Table 1. The sections were incubated with biotinylated
secondary antibody for 30 min at room temperature (Vector
Laboratories Limited, Peterborough, UK) 1:500 dilution in
10% normal serum in TBS followed by incubation with
avidin-peroxidase for 30 min (ABC-HRP, Vector Labs)
then developed with diaminobenzidine (DAB) solution
(Vector Labs), washed, dehydrated, and mounted using DPX
(Sigma–Aldrich, Poole, UK). For double immunofluorescence,
the Tyramide Signal Amplification (TSA) method was used,
permitting double-staining using same-species antibodies. At
the secondary antibody stage, sections were incubated with
HRP-conjugated secondary antibody for 30 min [ImmPRESS
HRP IgG (Peroxidase) Polymer Detection Kit, Vector Labs]
and then incubated in the dark for 10 min with fluorescein
tyramide diluted at 1/500 TSA fluorescein plus system reagent
(Perkin Elmer, Buckingham, UK) leaving fluorescent tags
covalently bound to the section. The sections were then
boiled in 10 mM citrate buffer pH 6 to remove all antibodies
and unbound fluorescein incubated first in 10% normal
serum and then with the second primary antibody for 2 h
at room temperature. The sections were again incubated
with an HRP-conjugated secondary antibody followed by
CY3 tyramide for 10 min (TSA CY3 plus system reagent,
Perkin Elmer). The sections were counterstained with 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI; Thermo
Fisher Scientific, Cramlington, UK) and mounted using
Vectashield Hardset Mounting Medium (Vector Labs).
Extensive washing of sections was carried out between
all incubations.
RNAseq
Full details of the origins, collection, preparation, sequencing,
and analysis of the human fetal RNA samples have been
previously described (Lindsay et al., 2016; Harkin et al.,
2017). Temporal lobes were removed and, in larger brains,
divided into frontal and posterior sections; the remaining cortex
was cut into coronal slices usually 5 mm wide containing
both medial and lateral wall. The entire RNAseq dataset
from which data were extracted for this study has been
deposited at www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-
4840. High-quality reads were then mapped to the human
reference genome hg38 with Tophat2 (Kim et al., 2013). Reads
aligned to genes and exons were counted with htseq-count
(Anders et al., 2014) and normalized RPKM calculated. Read
length was 101 bp before trimming and 85 bp after trimming
with no reads of<20 bp retained. The minimum number of reads
examined per sample was 63 million (average 90 million).
Imaging and Cell Quantification
Images from immunoperoxidase-stained sections were captured
using a Leica slide scanner and Zeiss Axioplan 2 microscope,
and from immunofluorescent-stained sections with a Zeiss
Axioimager Z2 apotome. Images were adjusted for brightness
and sharpness using Adobe PHOTOSHOP CS6 software.
Double labeling of cells for SCGN with either DLX2 or CalR
was counted from five sections selected at intervals along
the anterior-posterior axis of sections from two samples
aged 19 PCW. The sections were observed under medium
magnification; rectangular counting boxes 100 µm in width
were placed over the ventricular/subventricular zones (VZ/SVZ)
TABLE 1 | Primary antibodies used in this study.
Primary antibody Antigen Species Dilution Supplier RRID number
(where available)
SCGN
secretagogin
Recombinant protein fragment. See https://www.
proteinatlas.org/ENSG00000079689-SCGN/antibody
Rabbit Pycl 1/500 Sigma–Aldrich,
Poole, UK
AB_1079874
ANXA5
Annexin V
Purified human Annexin V. Mouse Mncl 1/200 Sigma–Aldrich AB_476772
MMP2
Matrix metalloprotease
Chinese hamster ovary cell line CHO-derived recombinant
human MMP-2
Mouse Mncl 1/100 R&D Systems,
Abingdon, UK.
AB_358834
GAD67
Glutamate decarboxylase
67 kD
Recombinant GAD67 protein
Human, rat, mouse-specific
Mouse Mncl 1/1,000 Merck Millipore,
Watford, UK
AB_2278725
DLX2
Distal-less homeobox 2
Amino acids 211–250 mapping within the internal region of
human DLX2.
Mouse Mncl 1/200 Santa Cruz,
Heidelberg,
Germany
Catalog number
SC393879
SP8
Specificity protein 8
Human SP8 Goat Pycl 1/500 Santa Cruz AB_2194626
Calretinin Recombinant rat calretinin Mouse Mncl 1/500 Merk Millipore AB_94259
COUP-TFII
Chicken ovalbumin
upstream promoter
transcription factor 2
Recombinant human COUP-TF II/NR2F2 Amino Acids
43–64
Mouse Mncl 1/500 R&D Systems,
Abingdon, UK
AB_2155627
NKX2.1
NK2 homeobox 1
Recombinant rat TTF-1 (NKX2.1) Mouse Mncl 1/150 Dako, Ely, UK Catalog number
M3575
LHX6
LIM/homeobox protein 6
Amino acids 1–75 mapping at the N-terminus of LHX6 of
human origin
Mouse Mncl 1/200 Santa Cruz AB_10649856
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and intermediate zone/cortical plate (IZ/CP) delineated by the
nuclear staining (DAPI).
RESULTS
SCGN Expression in the Forebrain
6.5 PCW–8 PCW
The earliest stage studied here was 6.5 PCW when the prelate
initially emerges (Meyer et al., 2000). Intense SCGN expression
was mainly restricted to the ventral telencephalon including
the post-mitotic zones of the LGE, medial ganglionic eminence
(MGE), and anterior entopeduncular nucleus/preoptic area
(AEP/POA) with no expression seen in the dorsal telencephalon
(Figure 1A). Besides, this stage was also marked the initial
emergence of early-born SCGN+ post-mitotic neurons of the
outer mantle layer of the dorsal thalamus (Figure 1B; Alzu’bi
et al., 2019). Although SCGN+ cells were also observed in
the post-mitotic zones of the MGE (Figures 1A,C), double
immunofluorescence for SCGN with pre- (NKX2.1) and
post-mitotic (LHX6) markers of MGE-derived cells (Butt et al.,
2008; Vogt et al., 2014; Sandberg et al., 2016) showed they
were expressed in separate populations of cells (data not shown)
indicating that SCGN+ cells are not likely to be generated in
the MGE, instead, they could have been born in the region of
the telencephalic stalk (POA; Figure 1D), and have migrated
dorsally via MGE toward the LGE and dorsal telencephalon.
SCGN+ cells were also observed in the post-mitotic layer
of the sub-pallial septum (Figure 1C) predominantly in
the LGE-like as opposed to MGE-like compartment (Alzu’bi
et al., 2017). To explore the identity of SCGN+ cells in
the various domains of the ventral telencephalon, double
immunofluorescent labeling demonstrated that most SCGN+
cells co-expressed the transcription factor SP8 (Figure 1E) and
a proportion co-expressed CalR (Figure 1F). Both SP8 and CalR
are markers of human CGE/dLGE derived GABAergic neurons
(Reinchisi et al., 2012; Hansen et al., 2013; Ma et al., 2013; Alzu’bi
et al., 2017).
Eight PCW marked the onset of SCGN immunoreactivity in
the human fetal cerebral cortex. At this stage, a small number
of SCGN+ cells appeared to be entering the cortex from either
the LGE/CGE (into the lateral and dorsal cortical wall) or the
septum (into the medial cortical wall; Figures 1G,H). On the
other hand, a much larger number of cells from ganglionic
eminences (GE) and septum appeared to be migrating ventro-
rostrally into the (RMS; Figure 1I) migrating towards the
olfactory bulb. Migratory behavior in groups of cells was assumed
if pronounced leading and trailing processes were orientated in
the same direction and there was the decreasing density of such
cells from the proposed origin to the proposed target of the
migrating cells.
SCGN Expression in the Forebrain
10–12 PCW
By 10 PCW, as an expression of SCGN is downregulated in the
thalamocortical afferents (Alzu’bi et al., 2019) many SCGN+ cells
had migrated into the cerebral cortex from the GE (Figure 2A).
SCGN+ cells from the septum were also observed entering the
dorsal and ventral medial wall of the anterior cortical regions
(Figures 2B,C). However, SCGN+ cells in the cortical wall were
mainly restricted to migratory cells in the SVZ; few were seen in
the CP at this stage (Figure 2D).
By 12 PCW, an extremely dense population of SCGN+ cells
entered the cortex from LGE/CGE (Figures 2E–G). SCGN+
cells also appeared to be following the curvature of the
pallial/subpallial boundary crossing the internal capsule in the
lateral migratory stream (LMS; Figure 2H) possibly guided by
the radial glia fiber fascicle that is present at the boundary
before they change direction to migrate radially into the future
olfactory and insular cortical areas (González-Arnay et al., 2017).
The CP, even in dorsal cortical regions, became more populated
with SCGN+ cells. Also, the VZ/SVZ provided a potential
migratory route for many SCGN+ neurons at this stage of
development (Figure 2I).
Double-labeling experiments for SCGN with either CalR or
COUP-TFII, a marker for CGE derived GABAergic neurons
(Alzu’bi et al., 2017) showed the only proportion of SCGN+
cells in the LGE/CGE co-expressed CalR (Figure 2J), whereas
the majority co-expressed COUP-TFII. Similar findings
were also observed in the cortical wall (Figures 2K,L).
No SCGN/LHX6 double labeling was observed in any
region of the cortical wall (Figure 2M) confirming that
the MGE is not a source of SCGN expressing cortical
GABAergic interneurons.
Robust Increase in SCGN Expressing
GABAergic Neurons During the
Midgestational Period
SCGN expression was also evaluated in the cortical wall of the
human fetal brain around the mid-gestational period. A robust
increase in the number of SCGN+ cells was observed in the
cortical VZ at 19 PCW (Figures 3A,B) as has previously been
described for DLX2+ and CalR+ neurons at this developmental
stage (Alzu’bi and Clowry, 2019). SCGN+ cells in the SVZ
mainly showed a migratory morphology that suggested they
were most likely following a radial path from the VZ towards
the CP; whereas a stream of cells at the interface between
the IZ and SVZ were mainly horizontally oriented perhaps
representing tangentially migrating cells (Figures 3B–D). In
the CP, SCGN+ cells were radially oriented and exhibited a
bipolar morphology, with a large number of SCGN+ cells also
appearing to descend from the MZ into the CP (Figure 3E)
indicating the MZ could be also considered as a migration route
for SCGN expressing cortical GABAergic neurons. Including
the MZ, a majority of SCGN+ cells in the cortical wall
co-expressed DLX2 (Figures 3F–H) and many co-expressed
GAD67 (Figure 3I) confirming that SCGN is predominantly
expressed in GABAergic neurons in the human cerebral cortex,
as previously shown (Raju et al., 2018).
To further differentiate the populations of SCGN+ cells
from CalR+ cells we found that proportion of SCGN+ cells
in the CP, but not the MZ, co-expressed CalR (Figure 3J)
confirming a distinct cellular identity for SCGN+ interneurons
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FIGURE 1 | Secretagogin (SCGN) expression 6.5–8 post-conceptional weeks (PCW). (A) Rostral coronal section of 6.5 PCW brain; intense SCGN expression in
ganglionic eminences (GE) preoptic area (POA) basal telencephalon and hypothalamus (HTh) and (B) Caudal thalamus (Th) and several locations in the
hypothalamus. (C) Horizontal section of 7.5 PCW brain; SCGN immunoreactivity in the medial ganglionic eminence (MGE), lateral ganglionic eminence (LGE), caudal
ganglionic eminence (CGE), septum (SEP), and POA. (D) A high magnification view of the boxed area in (C) shows many SCGN+ cells that appeared to enter MGE
from POA. (E) Double labeling for SCGN and specificity protein 8 (SP8) in LGE showing most SCGN+ cells were double-labeled with SP8, although there is a
population of SP8+ only cells in the dorsal most LGE. (F) Double labeling for SCGN and calretinin (CalR) in LGE showing only a proportion of SCGN+ cells
co-expressed CalR. (G–I) The rostral coronal section at 8 PCW showing intense SCGN expression in LGE, septum, and rostral migratory stream (RMS, G). Few
SCGN+ cells enter cortex from LGE (H). Cells from LGE and septum appeared to be mainly migrating into RMS at this stage (I). Scale bars: 1 mm in (C) (and for
A,B) and (G), 50 µm in (D,F) (and for E), and (I) (and for H).
in the MZ. CalR+ cells in the MZ include Cajal-Retzius cells
(Meyer et al., 2000) that co-express their markers Reelin and
P73 (Figures 3K,L) whereas SCGN+ cells were exclusively
GABAergic neurons co-expressing GAD67 but not Reelin
(Figures 3I,M). Reelin is also a marker of some cortical
inhibitory interneurons, including neurogliaform (NGCs) and
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FIGURE 2 | SCGN expression 10–12 PCW. At 10 PCW (A) high expression observed in LGE and SEP. Higher magnification insets show the migration of SCGN+
cells from septum into dorsomedial (B) and ventromedial (C) cortex. In dorsal cortex (D) a small number of SCGN+ cells seen predominantly migrating through
subventricular zone (SVZ). By 12 PCW (E,F), SCGN+ expression concentrated in dorsal LGE and low in MGE with higher magnification inset showing SCGN+ cells
crossing the pallial/subpallial border to invade lateral cortex (G) and also migrating ventrolaterally in the lateral migratory stream (LMS) towards olfactory cortex (OC)
and amygdala (E,F). Some SCGN+ exit LMS to populate insula (Ins, F,H). In the dorsal cortex (I) there are increased numbers of SCGN+ cells compared to 10 PCW
and throughout the cortical wall while still favoring the SVZ. A proportion of SCGN+ cells in the LGE co-express CalR (J) but a higher number still co-express
COUP-TFII both in the LGE (K) and the cortical wall (L). However, no co-expression with LHX6 observed (M). Scale bars: 1 mm in (A) (and for E); 50 µm in (D) (and
for B,C); in (H,I,L,M), and in (K) (and for J). .
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FIGURE 3 | SCGN expression at 19 PCW. (A) The coronal section at 19 PCW with intense SCGN expression in CGE but also in ventricular zone (VZ) of the cortical
wall (B) and in the marginal zone (MZ, E) otherwise moderate expression throughout the cortical wall. Panels (B–D) show that SCGN+ cells exhibit morphology of
predominantly tangentially migrating cells in intermediate zone (IZ) but are sparser in SVZ, unlike 10–12 PCW, and show predominantly radial migratory morphology.
In the cortical plate (CP) SCGN+ cells also have predominantly radial migratory morphology (E). (F) A high proportion of SCGN+ neurons co-expressed DLX2 in both
CP/MZ (G) and SVZ (H). SCGN+ neurons in MZ, in particular, strongly co-expressed GAD67 (I). Co-expression with CalR was abundant in the CP but in MZ, CalR
and SCGN showed largely separate patterns of expression (J). In the outer, subgranular layer of the MZ, CalR primarily co-localized with markers of Cajal Retzius
cells, Reelin and P73 (K,L) whereas SCGN did not (M). Scale bars: 2 mm in (A); 100 µm in (B); 50 µm in (D) (and for C) (F,J) (and for G–I) and in (M) (and for L,K).
single bouquet-like cells (SBCs) in layer I of the adult rodent
neocortex (Jiang et al., 2015; Cadwell et al., 2016) indicating
these cell types may not express SCGN. Finally, to investigate
the proportions of cortical GABAergic neurons that express
CalR and SCGN in the cortical wall, we counted the number
of DLX2+ cells that co-expressed each protein. A higher
proportion of DLX2+ GABAergic neuron precursors expressed
SCGN than CalR; 58% (±3%; standard error of the mean) of
interneuron precursors co-expressed SCGN, compared to 45%
(±2%) expressing CalR.
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FIGURE 4 | RNAseq for cortical expression of SCGN, ANXA5 and MMP2,
7.5–17 PCW. Changes of expression (normalized RPKM) with age. SCGN
expression showed steady and statistically significant increases with age (A)
whereas ANXA5 showed a significant decrease in expression (B). MMP2 was
modestly expressed at all ages studied but expression increased to a small
but significant degree with age (C). Correlation coefficients (r) and p-values
for r (p) are displayed on the charts.
The Co-expression of Secretagogin With
Either Annexin V or Matrix
Metalloprotease-2
Finally, we set out to explore one potential role of SCGN in
the transduction of calcium signaling via ANXA5 to evoke the
release of MMP2. Using RNAseq data (Lindsay et al., 20162)
from samples from 7.5 to 17 PCW human fetal brain and
immunohistochemical analysis, we first identified the expression
level of both ANXA5 and MMP2 and explored their presence
in SCGN+ cells. SCGN mRNA expression levels significantly
increased with age (Figure 4A) in agreement with our
immunohistochemical data (Figures 1–3). Expression appeared
higher in the frontal and temporal cortex at all ages studied (not
shown) in agreement with observations for other genes expressed
by immature cortical GABAergic neurons (Molnár et al., 2019).
The expression of ANXA5 was generally higher than SCGN
but decreased significantly with age (Figure 4B) and statistical
tests for correlated expression of SCGN and ANXA5 in tissue
2www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4840
FIGURE 5 | Expression of ANXA5 and MMP2 in the cortical wall. (A) At
10 PCW there was strong immunoreactivity for ANXA5 throughout cortical
wall especially in MZ, VZ, and blood vessels (∗). (B) MMP2 expression was
entirely confined to CP. (C) By 19 PCW, ANXA5 expression was still strong in
VZ, SVZ (E), and blood vessels (∗) but much reduced in MZ. However, many
positive cells present in the upper subplate (uSP). Occasional cells with
neuronal morphology in CP were also strongly immunostained for ANXA5 (D).
In SVZ, both SCGN+ (arrowheads) and SCGN− (arrows) cells expressed
ANXA5 (F). MMP2 expression was largely confined to CP (but not MZ, see
G,H) but there was also expressed in the VZ and SVZ (G,I) where
MMP2 immunoreactivity was found in close apposition to SCGN+ cells
(arrowhead, J). MZ, marginal zone; CP, cortical plate; pSP, presubplate; uSP,
upper subplate; lSP, lower subplate; IZ, intermediate zone; SVZ,
subventricular zone; VZ, ventricular zone. Scale bars: 100 µm in (F) (and for
A) in (G) (and for B); 50 µm in (J) (and for C–E, H and I).
samples found no evidence for this. MMP2 showed relatively low
levels of expression with a slight but statistically significant trend
towards increased expression with age (Figure 4C). Therefore,
these observations found no evidence for widespread, correlated
expression of these genes at the mRNA level in the developing
human cerebral cortex.
Therefore, we turned to immunohistochemical analysis to see
if the subsets of cells co-expressed these genes. There was an
intense and widespread expression of ANXA 5 throughout the
cortical wall at 10 PCW, although expression was strongest in
the MZ, VZ, and in association with blood vessels (Figure 5A).
Expression of MMP2, however, was restricted to the CP
(Figure 5F). By 19 PCW, expression of ANXA5 appeared to
have decreased slightly, in agreement with the RNAseq data. It
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was still strongly associated with blood vessels and also showed
strong expression in a small population of cells in the CP and
somewhat larger populations of cells in the proliferative zones
(Figures 5B–D). Many ANXA5+ cells were present in the upper
subplate, however, ANXA5 immunoreactivity was not observed
in the MZ at this developmental stage (Figure 5B). By 19 PCW,
the strongest expression of MMP2 was observed in the CP and
pial surface but not in the MZ, with moderate expression also
seen in the outer subventricular zone, and ventricular zone (VZ;
Figures 5G–I).
At 19 PCW several SCGN+ cells co-expressed ANXA5
(Figure 5E), with also a proportion of SCGN+ cells expressing
MMP2 on their extracellular surface (Figure 5J) however these
two types of double-labeled cells were only observed in the
VZ/SVZ which becomes a major tangential migratory route for
GABAergic neuron precursors (post-mitotic, migratory) at this
stage of development (Alzu’bi and Clowry, 2019) suggesting that
SCGN could also have a role in GABAergic neuron migration in
the human cortex. However, it is worth mentioning that neither
the expression of ANXA5 or MMP2 was specific to SCGN+ cells
but that they were also expressed by other cell types including
dorsal progenitor cells and post-mitotic neurons of the CP which
indicates the widespread role of MMP2 activity, possibly in
neural migration in the developing human cortex, but not limited
to SCGN+ cells.
DISCUSSION
In this study, we have confirmed that a substantial proportion
of cortical GABAergic neurons express SCGN by mid-gestation
in the developing human forebrain and shown that a higher
proportion of cortical GABAergic neurons express SCGN than
express CalR. Reporting on expression at younger stages for the
first time, we observed that SCGN expression by GABAergic
neuron precursors occurs at all stages of development, and we
observed four major origins for SCGN+ GABAergic neurons,
the CGE, LGE, subpallial septum, and preoptic area. SCGN+
cells predominantly co-expressed SP8 but not markers for cells of
MGE origin. The earliest born SCGN+ cells appeared to mainly
target the basolateral complex (via LMS) and the olfactory bulb
(via RMS). After 8 PCW, large streams of SCGN+ cells also
started migrating into the neocortex.
Multiple Origins of SCGN Expressing
Interneurons
These results suggest that the origin of SCGN expressing
GABAergic neurons in the fetal human neocortex is not
restricted to the CGE/LGE; the subpallial septum and POA also
contribute to a proportion of these populations. We have recently
discovered that the septum is a major contributor of GABAergic
neuron precursors to the human cortex via medial migration
routes not observed in rodent models (Alzu’bi et al., 2017; Alzu’bi
and Clowry, 2019). The subpallial septum can be divided into
MGE-like and LGE-like domains, based on gene expression
patterns (Alzu’bi et al., 2017; Clowry et al., 2018) and as would be
predicted, SCGN+ interneuron precursors arose from the more
dorsal LGE-like domain.
In rodents, the VZ of the POA is the birthplace for about
10% of the total number of cortical interneurons. Although
the comparatively small region of neurogenesis, it contributes a
diversity of GABAergic neuron subtypes to the cerebral cortex
(Gelman et al., 2009). They arise from two distinct sub-domains,
the Nkx2.5 expressing, more dorsal pPOA1 which gives rise to
principally neurogliaform cells (Gelman et al., 2011; Niquille
et al., 2018) and the Dbx1 expressing, more ventral pPOA2 which
gives rise to a great diversity of cell types including parvalbumin
and somatostatin expressing neurons typical of MGE-derived
interneurons (although they do not express Lhx6) and Reelin,
Neuropeptide Y and some CalR expressing neurons typical of
CGE-derived neurons (Gelman et al., 2011; Asgarian et al., 2019).
In the present study, SCGN was expressed by neurons present
in the mantle zone over both parts of the POA and could
thus potentially be expressed by a wide range of interneurons
during development. However, we found no evidence of the
co-expression of neurogliaform cell markers in SCGN+ neurons
in the MZ (Figure 3).
Primates display complexity in layer I of the cortex not
found in rodents. In humans, around 11 PCW, the subpial
granular layer (SGL) starts forming from cells observed to
spread from the olfactory region to the nearby anterior/ventral
cortex (Zecevic and Rakic, 2001; Meyer and González-Gómez,
2018). By 16 PCW the SGL covers the entire cortical surface
of the forebrain, forming the most superficial part of the
MZ (Meyer and González-Hernández, 1993) and consisting of
small GABAergic cells previously reported to almost entirely
co-express CalR (Meyer and González-Gómez, 2018) as well
as large Reelin-positive Cajal–Retzius cells (Meyer et al., 2002).
Small non-GABAergic CalR+ neurons are found in the deep
MZ at the boundary with the CP (Meyer et al., 2000). We
have found that there is a distinct population of SCGN+/
GAD67+/CALR−neurons separate from the CALR+/GAD67+
neurons previously described. Some of the GABAergic cells of
the SGL can undergo inward migration into the CP (Zecevic
and Rakic, 2001; Rakic and Zecevic, 2003). Perhaps SCGN
expression sorts inward migrating GABAergic neurons from
the neurogliaform cells and small CR+ neurons that remain
in the MZ.
By mid-gestation, there was a substantial increase in SCGN+
cells in the proliferative VZ and SVZ. Previous studies have
provided evidence that, at this stage of development, there is
an increased incidence of neurogenesis of GABAergic neurons,
particularly those expressing calretinin, within the cerebral
cortex itself (Letinic et al., 2002; Petanjek et al., 2009; Jakovcevski
et al., 2011; Hladnik et al., 2014) therefore it is possible that
some of these SCGN+ cells could be proliferative, or derived from
proliferating cells in the dorsal telencephalon. Even though there
is still appreciable Ki67 expression in the VZ at mid-gestation
(Petanjek and Kostovic´, 2012; Alzu’bi and Clowry, 2019) we
would conclude that the proportion of Ki67+ cells that are
GABAergic neuron progenitors must be quite small as at 19PCW
nearly all SCGN+ cells express DLX2 (a marker for GABAergic
neuron progenitors and neuroblasts, see Figure 3) but nearly
all DLX2+ cells are KI67− (i.e., non-proliferative, Alzu’bi and
Clowry, 2019).
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In summary, we have observed that approximately 60%
of all cortical GABAergic neuron precursors (defined by
DLX2 expression) co-express SCGN by mid-gestation in human,
compared to only 45% that express CalR (this study) and
up to 50% that is estimated to derive from the human CGE
(Hansen et al., 2013) in total. This suggests the SCGN+ positive
interneurons form the most populous subgroup of interneurons
in the human neocortex. However, this is potentially a very
diverse population as SCGN neurons can derive from the POA,
this may include some cells with an MGE-like phenotype, that
is, expressing parvalbumin and somatostatin when mature. It
appears that SCGN expression may confer the increased capacity
for neurite outgrowth (Raju et al., 2018) or specific migratory
abilities to a large but diverse population of GABAergic neurons.
Expression of MMP2 and ANXA5
Although, we found evidence of SCGN being co-expressed with
either MMP2 or ANXA5, it was more striking to note the
extensive independent expression of these three proteins. Even
though MMP2 is proposed to promote neuroblast migration
and neurite outgrowth by remodeling the local extracellular
matrix (ECM; Lee et al., 2006; Mao et al., 2016; Hanics et al.,
2017) it showed strong localization to the CP where cortical
neurons stop migrating and where the cells are densely packed
with little neurite outgrowth, or ingrowth of afferents, at this
stage of development (Bystron et al., 2008). Furthermore, the
effect of MMP2 on neural progenitors appears to be to maintain
proliferation and prevent differentiation (Sinno et al., 2013; Shu
et al., 2018) therefore expression of MMP2 in the CP appears
paradoxical. However, perhaps secretion of MMP2 is required
for neurons destined to inhabit the upper layers of the CP to
migrate past densely packed neurons already stationary in the
lower layers.
ANXA5 principally showed strong expression in the
endothelial cells of blood vessels in the cortical wall. ANXA5 is
secreted from endothelial cells where it interacts with
phosphatidylserine (PS) abnormally expressed on the exofacial
part of cell surface membrane in a Ca2+ dependent way to
regulate coagulation and thus inhibit thrombosis (Flaherty et al.,
1990; Van Heerde et al., 1994; Rao and Pendurthi, 2012). Our
observations suggest it may also play this role in the developing
cerebral vasculature. However, ANXA5 was also expressed
by neuroblasts and neuronal progenitors in the proliferative
zones. ANXA5 can bind to PS on the surface of cells undergoing
apoptosis, inhibiting this process (Van Genderen et al., 2008) and
in the brain the presence of ANXA5 in the ECM is indicative of
ongoing neuronal death (Hefter et al., 2016). Thus, ANXA5 may
play a role in modulating cell death during cortical development.
ANXA5 was expressed by more mature neurons but not
exclusively by SCGN neurons or neurons that co-expressed
MMP2. At the early stages of CP development, ANXA5 showed
the strongest expression in both the proliferative zones and in
the more mature MZ but intriguingly, not the developmentally
similar presubplate.
By mid-gestation intense expression was observed in a small
subset only of cells resembling migrating neurons in the CP but
was more extensively expressed in cells in the upper subplate
(SP) at the boundary with the CP. The SP is known to contain
a rich ECM, and by mid-gestation can be divided into layers
containing cells of different phenotypes (Wang et al., 2010;
Kostovic´ et al., 2019). The upper SP contains a higher cell density
than other SP strata (Kostovic´ et al., 2019) and a higher density
of acetylcholinesterase expressing thalamic and basal forebrain
afferents (Kostovic´ and Goldman Rakic´, 1983; Kostovic´ and
Rakic´, 1984) and synapses made between afferents, SP neurons
and dendrites descending from the lower levels of the CP
(Mrzljak et al., 1988; Kostovic´ and Rakic´, 1990) although, by this
stage, it does not appear to be expressed in the other synapse
dense region, the MZ (Figure 5). We would tentatively suggest
that in this situation, ANXA5 is functioning intracellularly in
active neurons in calcium-dependent signaling.
We have found evidence for SCGN+ neurons that
co-expressed either ANXA5 or MMP2 and these were
predominantly found within the SVZ. It seems probable
(although not proven here) that SCGN+ neurons express both
these proteins and may behave like cells of the adult RMS,
remodeling the local ECM in response to CA2+ signaling to
permit migration of these cells and/or other cells through this
region which at this stage of development makes the transition
from a predominantly proliferative zone to predominantly a
zone for tangential migration of late-born GABAergic neurons
(Alzu’bi and Clowry, 2019).
CONCLUSIONS
The expression of SCGN by a considerable proportion of human
cortical GABArgic neuron precursors of potentially diverse
mature phenotypes is a striking but enigmatic observation.
Raju et al.’s (2018) demonstration that it may confer the
capacity for more extensive dendritic tree formation than found
in corresponding rodent interneurons is persuasive but does
not address why SCGN is expressed from the earliest stages
of post-mitotic development. SCGN may also play a role
in interneuron migration and perhaps in the elaboration of
migratory routes we have observed in humans compared to the
rodent cortex (Alzu’bi et al., 2017; Alzu’bi and Clowry, 2019;
Molnár et al., 2019).
DATA AVAILABILITY STATEMENT
The datasets presented in this study can be found in online
repositories. The names of the repository/repositories and
accession number(s) can be found below: https://www.ebi.ac.
uk/arrayexpress/; www.ebi.ac.uk/arrayexpress/experiments/
E-MTAB-4840.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by the Newcastle and North Tyneside NHS Health
Authority Joint Ethics Committee. The patients/participants
provided their written informed consent to participate in
this study.
Frontiers in Neuroanatomy | www.frontiersin.org 10 September 2020 | Volume 14 | Article 61
Alzu’bi and Clowry Secretagogin in Human Cortical Development
AUTHOR CONTRIBUTIONS
GC contributed to study design, data analysis and manuscript
preparation. AA contributed to study design, data collection, data
analysis and manuscript preparation.
FUNDING
The human fetal material was provided by the Joint UK
MRC/Wellcome Trust funded (grants # 099175/Z/12/Z and
MR/R006237/1) Human Developmental Biology Resource
(www.hdbr.org). The RNA seq study was funded by a grant
from UK MRC (grant # MC/PC/13047). AA is funded by
a grant from the Deanship of Scientific Research, Yarmouk
University, Jordan.
ACKNOWLEDGMENTS
We are grateful to the staff of the Human Developmental
Biology Resource for their help and support. We are
grateful to Dr. Yaobo Xu for help with analyzing
RNAseq data.
REFERENCES
Alzu’bi, A., and Clowry, G. J. (2019). Expression of ventral telencephalon
transcription factors ASCL1 and DLX2 in the early fetal human cerebral cortex.
J. Anat. 235, 555–568. doi: 10.1111/joa.12971
Alzu’bi, A., Homman-Ludiye, J., Bourne, J. A., and Clowry, G. J. (2019).
Thalamocortical afferents innervate the cortical subplate much earlier in
development in primate than in rodent. Cereb. Cortex 29, 1706–1718.
doi: 10.1093/cercor/bhy327
Alzu’bi, A., Lindsay, S., Kerwin, J., Looi, S. J., Khalil, F., and Clowry, G. J.
(2017). Distinct cortical and sub-cortical neurogenic domains for GABAergic
interneuron precursor transcription factors NKX2. 1, OLIG2 and COUP-TFII
in early fetal human telencephalon. Brain Struct. Funct. 222, 2309–2328.
doi: 10.1007/s00429-016-1343-5
Anders, S., Pyl, T. P., and Huber, W. (2014). HTSeq—a Python framework
to work with high-throughput sequencing data. Bioinformatics 31, 166–169.
doi: 10.1093/bioinformatics/btu638
Asgarian, Z., Magno, L., Ktena, N., Harris, K. D., and Kessaris, N. (2019).
Hippocampal CA1 somatostatin interneurons originate in the embryonic
MGE/POA. Stem Cell Reports 13, 793–802. doi: 10.1016/j.stemcr.2019.
09.008
Attems, J., Quass, M., Gartner, W., Nabokikh, A., Wagner, L., Steurer, S., et al.
(2007). Immunoreactivity of calcium binding protein secretagogin in the
human hippocampus is restricted to pyramidal neurons. Exp. Gerontol. 42,
215–222. doi: 10.1016/j.exger.2006.09.018
Butt, S. J. B., Sousa, V. H., Fuccillo, M. V., Hjerling-Leffler, J., Miyoshi, G.,
Kimura, S., et al. (2008). The requirement of Nkx2–1 in the temporal
specification of cortical interneuron subtypes. Neuron 59, 722–732.
doi: 10.1016/j.neuron.2008.07.031
Bystron, I., Blakemore, C., and Rakic, P. (2008). Development of the human
cerebral cortex: Boulder Committee revisited. Nat. Rev. Neurosci. 9, 110–122.
doi: 10.1038/nrn2252
Cadwell, C. R., Palasantza, A., Jiang, X., Berens, P., Deng, Q., Yilmaz, M., et al.
(2016). Electrophysiological, transcriptomic and morphologic processing of
single neurons using patch-seq. Nat. Biotechnol. 34, 199–203. doi: 10.1038/
nbt.3445
Clowry, G. J., Alzu’bi, A., Harkin, L. F., Sarma, S., Kerwin, J., and Lindsay, S.
(2018). Charting the protomap of the human telencephalon. Semin. Cell Dev.
Biol. 76, 3–14. doi: 10.1016/j.semcdb.2017.08.033
Ellis, J. K., Sorrells, S. F., Mikhailova, S., Chavali, M., Chang, S., Sabeur, K.,
et al. (2019). Ferret brain possesses young interneuron collections equivalent
to human postnatal migratory streams. J. Comp. Neurol. 527, 2843–2859.
doi: 10.1002/cne.24711
Flaherty, M. J., West, S., Heimark, R. L., Fujikawa, K., and Tait, J. F. (1990).
Placental anti-coagulant protein-1—measurement in extracellular fluids and
cells of the hemostatic system. J. Lab. Clin. Med. 115, 174–181.
Gartner, W., Lang, W., Leutmetzer, F., Domanovits, H., Waldhäusl, W., and
Wagner, L. (2001). Cerebral expression and serum detectability of secretagogin,
a recently cloned EF-hand Ca2+-binding protein. Cereb. Cortex 11, 1161–1169.
doi: 10.1093/cercor/11.12.1161
Gelman, D., Griveau, A., Dehorter, N., Teissier, A., Varela, C., Pla, R., et al.
(2011). A wide diversity of cortical GABAergic interneurons derives from the
embryonic preoptic area. J. Neurosci. 31, 16570–16580. doi: 10.1523/jneurosci.
4068-11.2011
Gelman, D. M., Martini, F. J., Nobrega-Pereira, S., Pierani, A., Kessaris, N., and
Marín, O. (2009). The embryonic preoptic area is a novel source of cortical
GABAergic interneurons. J. Neurosci. 29, 9380–9389. doi: 10.1523/jneurosci.
0604-09.2009
Gerrelli, D., Lisgo, S., Copp, A. J., and Lindsay, S. (2015). Enabling research with
human embryonic and fetal tissue resources. Development 142, 3073–3076.
doi: 10.1242/dev.122820
González-Arnay, E., González-Gómez, M., and Meyer, G. (2017). A radial glia
fascicle leads principal neurons from the pallial-subpallial boundary into the
developing human insula. Front. Neuroanat. 11:111. doi: 10.3389/fnana.2017.
00111
Hanics, J., Szodorai, E., Tortoriello, G., Malenczyk, K., Keimpema, E., Lubec, G.,
et al. (2017). Secretagogin-dependent matrix metalloprotease-2 release from
neurons regulates neuroblast migration. Proc. Natl. Acad. Sci. U S A 114,
E2006–E2015. doi: 10.1073/pnas.1700662114
Hansen, D. V., Lui, J. H., Flandin, P., Yoshikawa, K., Rubenstein, J. L., Alvarez-
Buylla, A., et al. (2013). Non-epithelial stem cells and cortical interneuron
production in the human ganglionic eminences. Nat. Neurosci. 16, 1576–1587.
doi: 10.1038/nn.3541
Harkin, L. F., Lindsay, S. J., Xu, Y., Alzu’bi, A., Ferrera, A., Gullon, E. A.,
et al. (2017). Neurexins 1–3 each have a distinct pattern of expression in
the early developing human cerebral cortex. Cereb. Cortex 27, 216–232.
doi: 10.1093/cercor/bhw394
Hefter, D., Kaiser, M., Weyer, S. W., Papageorgiou, I. E., Both, M., Kann, O.,
et al. (2016). Amyloid precursor protein protects neuronal network function
after hypoxia via control of voltage-gated calcium channels. J. Neurosci. 36,
8356–8371. doi: 10.1523/jneurosci.4130-15.2016
Hern, W. M. (1984). Correlation of fetal age and measurements between 10 and
26 weeks of gestation. Obstet. Gynecol. 63, 26–32.
Hladnik, A., Džaja, D., Darmopil, S., Jovanov-Miloševic´, N., and Petanjek, Z.
(2014). Spatio-temporal extension in site of origin for cortical calretinin
neurons in primates. Front. Neuroanat. 8:50. doi: 10.3389/fnana.2014.
00050
Jakovcevski, I., Mayer, N., and Zecevic, N. (2011). Multiple origins of human
neocortical interneurons are supported by distinct expression of transcription
factors. Cereb. Cortex 21, 1771–1782. doi: 10.1093/cercor/bhq245
Jiang, X., Shen, S., Cadwell, C. R., Berens, P., Sinz, F., Ecker, A. S., et al. (2015).
Principles of connectivity among morphologically defined cell types in adult
neocortex. Science 350:aac9462. doi: 10.1126/science.aac9462
Khandewal, R., Sharma, A. K., Chadalawada, S., and Sharma, Y. (2017).
Secretagogin is a redox-responsive Ca2+ Sensor. Biochemistry 56, 411–420.
doi: 10.1021/acs.biochem.6b00761
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., and Salzberg, S. L. (2013).
TopHat2: accurate alignment of transcriptomes in the presence of insertions,
deletions and gene fusions. Genome Biol. 14:R36. doi: 10.1186/gb-2013-14-
4-r36
Kim, J., Richter, W., Aanstoot, H. J., Shi, Y., Fu, Q., Rajotte, R., et al.
(1993). Differential expression of GAD65 and GAD67 in human, rat and
mouse pancreatic islets. Diabetes 142, 1799–1808. doi: 10.2337/diabetes.42.
12.1799
Frontiers in Neuroanatomy | www.frontiersin.org 11 September 2020 | Volume 14 | Article 61
Alzu’bi and Clowry Secretagogin in Human Cortical Development
Kostovic´, I., and Goldman Rakic´, P. S. (1983). Transient cholinesterase staining in
the mediodorsal nucleus of the thalamus and its connections in the developing
human and monkey brain. J. Comp. Neurol. 219, 431–447. doi: 10.1002/cne.
902190405
Kostovic´, I., Išasegi, I. Ž., and Krsnik, Ž. (2019). Sublaminar organisation of the
human subplate: developmental changes in the distribution of neurons, glia,
growing axons and extracellular matrix. J. Anat. 235, 481–506. doi: 10.1111/joa.
12920
Kostovic´, I., and Rakic´, P. (1984). Development of prestriate visual
projections in the monkey and human fetal cerebrum revealed by transient
cholinesterase staining. J. Neurosci. 4, 25–42. doi: 10.1523/jneurosci.04-01-
00025.1984
Kostovic´, I., and Rakic´, P. (1990). Developmental history of the transient
subplate zone in the visual and somatosensory cortex of the macaque
monkey and human brain. J. Comp. Neurol. 297, 441–470. doi: 10.1002/cne.
902970309
Kunwar, A. J., Rickmann, M., Backofen, B., Browski, S. M., Rosenbusch, J.,
Schoning, S., et al. (2011). Lack of endosomal SNAREs vti1a and vti1b led to
significant impairments in neuronal development. Proc. Natl. Acad. Sci. U S A
108, 2575–2580. doi: 10.1073/pnas.1013891108
Lee, S. R., Kim, H. Y., Rogowska, J., Zhao, B. Q., Bhide, P., Parent, J. M.,
et al. (2006). Involvement of matrix metalloproteinase in neuroblast cell
migration from the subventricular zone after stroke. J. Neurosci. 26, 3491–3495.
doi: 10.1523/jneurosci.4085-05.2006
Letinic, K., Zoncu, R., and Rakic, P. (2002). Origin of GABAergic neurons in the
human neocortex. Nature 417, 645–649. doi: 10.1038/nature00779
Lindsay, S., Xu, Y., Lisgo, S., Harkin, L. F., Copp, A., Gerrelli, D., et al. (2016). A
unique resource for global and individual gene expression studies during early
human brain development. Front. Neuroanat. 10:86. doi: 10.3389/fnana.2016.
00086
Lois, C., and Alvarez-Buylla, A. (1994). Long-distance neuronal migration in
the adult mammalian brain. Science 264, 1145–1148. doi: 10.1126/science.
8178174
Ma, T., Wang, C., Wang, L., Zhou, X., Tian, M., Zhang, Q., et al. (2013). Subcortical
origins of human and monkey neocortical interneurons. Nat. Neurosci. 16,
1588–1597. doi: 10.1038/nn.3536
Mao, W., Xin, Y., Qin, J., Tian, M., and Jin, G. (2016). CXCL12/CXCR4 axis
improves migration of neuroblasts along corpus callosum by stimulating
MMP-2 secretion after traumatic brain injury in rats. Neurochem. Res. 41,
1315–1322. doi: 10.1007/s11064-016-1831-2
Meyer, G., and González-Gómez, M. (2018). The subpial granular layer and
transient versus persisting Cajal-Retzius neurons of the fetal human cortex.
Cereb. Cortex 28, 2043–2058. doi: 10.1093/cercor/bhx110
Meyer, G., and González-Hernández, T. (1993). Developmental changes in
layer I of the human neocortex during prenatal life: a DiI-tracing and
AChE and NADPH-d histochemistry study. J. Comp. Neurol. 338, 317–336.
doi: 10.1002/cne.903380302
Meyer, G., Perez-Garcia, C. G., Abraham, H., and Caput, D. (2002). Expression
of p73 and Reelin in the developing human cortex. J. Neurosci. 22, 4973–4986.
doi: 10.1523/JNEUROSCI.22-12-04973.2002
Meyer, G., Schaaps, J. P., Moreau, L., and Goffinet, A. M. (2000). Embryonic
and early fetal development of the human cerebral cortex. J. Neurosci. 20,
1858–1868. doi: 10.1523/JNEUROSCI.20-05-01858.2000
Molnár, Z., Clowry, G. J., Šestan, N., Alzu’bi, A., Bakken, T., Hevner, R. F.,
et al. (2019). New insights into the development of the human cerebral cortex.
J. Anat. 235, 432–451. doi: 10.1111/joa.13055
Mrzljak, L., Uylings, H. B., Kostovic´, I., and Van Edan, C. G. (1988). Prenatal
development of neurons in the human prefrontal cortex: I. A qualitative Golgi
study. J. Comp. Neurol. 271, 355–386. doi: 10.1002/cne.902710306
Niquille, M., Limoni, G., Markopoulos, F., Cadilhac, C., Prado, J., Holtmaat, A.,
et al. (2018). Neurogliaform cortical interneurons derive from cells in the
preoptic area. eLife 7:e32017. doi: 10.7554/eLife.32017
Paredes, M. F., James, D., Gil-Perotin, S., Kim, H., Cotter, J. A., Ng, C., et al.
(2016). Extensive migration of young neurons into the infant human frontal
lobe. Science 354:aaf7073. doi: 10.1126/science.aaf7073
Petanjek, Z., and Kostovic´, I. (2012). Epigenetic regulation of fetal brain
development and neurocognitive outcome. Proc. Natl. Acad. Sci. U S A 109,
11062–11063. doi: 10.1073/pnas.1208085109
Petanjek, Z., Kostovic´, I., and Esclapez, M. (2009). Primate-specific origins
and migration of cortical GABAergic neurons. Front. Neuroanat. 3:26.
doi: 10.3389/neuro.05.026.2009
Raju, C. S., Spatazza, J., Stanco, A., Larimer, P., Sorrells, S. F., Kelley, K. W.,
et al. (2018). Secretagogin is expressed by developing neocortical
GABAergic neurons in humans but not mice and increases neurite arbor
size and complexity. Cereb. Cortex 28, 1946–1958. doi: 10.1093/cercor/
bhx101
Rakic, S., and Zecevic, N. (2003). Emerging complexity of layer I in
human cerebral cortex. Cereb. Cortex 13, 1072–1083. doi: 10.1093/cercor/13.
10.1072
Rao, L. V. M., and Pendurthi, U. R. (2012). Regulation of tissue factor coagulant
activity on cell surfaces. J. Thromb. Haemost. 10, 2242–2253. doi: 10.1111/jth.
12003
Reinchisi, G., Ijichi, K., Glidden, N., Jakovcevski, I., and Zecevic, N. (2012).
COUP-TFII expressing interneurons in human fetal forebrain. Cereb. Cortex
22, 2820–2830. doi: 10.1093/cercor/bhr359
Rogstam, A., Linse, S., Lindqvist, A., James, P., Wagner, L., and Berggard, T.
(2007). Binding of calcium ions and SNAP-25 to the hexa EF-hand protein
secretagogin. Biochem. J. 401, 353–363. doi: 10.1042/bj20060918
Romanov, R. A., Alpár, A., Zhang, M. D., Zeisel, A., Calas, A., Landry, M.,
et al. (2015). A secretagogin locus of the mammalian hypothalamus
controls stress hormone release. EMBO J. 34, 36–54. doi: 10.15252/embj.
201488977
Sanai, N., Nguyen, T., Ihrie, R. A., Mirzadeh, Z., Tsai, H.-H., Wong, M.,
et al. (2011). Corridors of migrating neurons in the human brain
and their decline during infancy. Nature 478, 382–386. doi: 10.1038/
nature10487
Sandberg, M., Flandin, P., Silberberg, S., Su-Feher, L., Price, J. D., Hu, J. S., et al.
(2016). Transcriptional networks controlled by NKX2–1 in the development of
forebrain GABAergic neurons. Neuron 91, 1260–1275. doi: 10.1016/j.neuron.
2016.08.020
Schmidt, H (2012). Three functional facets of calbindin D-28k. Front. Mol.
Neurosci. 5:25. doi: 10.3389/fnmol.2012.00025
Schwaller, B. (2009). The continuing disappearance of ‘‘pure’’ Ca2+ buffers. Cell.
Mol. Life Sci. 66, 275–300. doi: 10.1007/s00018-008-8564-6
Schwaller, B. (2014). Calretinin: from a ‘‘simple’’ Ca2+ buffer to a multifunctional
protein implicated in many biological processes. Front. Neuroanat. 8:3.
doi: 10.3389/fnana.2014.00003
Shu, T., Liu, C., Pang, M., Wang, J., Liu, B., Zhou, W., et al. (2018). Effects and
mechanisms of matrix metalloproteinase2 on neural differentiation of induced
pluripotent stem cells. Brain Res. 1678, 407–418. doi: 10.1016/j.brainres.2017.
11.006
Sinno, M., Biagioni, S., Ajmone-Cat, M. A., Pafumi, I., Caramanica, P., Medda, V.,
et al. (2013). The matrix metalloproteinase inhibitor marimastat promotes
neural progenitor cell differentiation into neurons by gelatinase-independent
TIMP-2-dependent mechanisms. StemCells Dev. 22, 345–358. doi: 10.1089/scd.
2012.0299
Tapia-González, S., Insausti, R., and De Felipe, J. (2020). Differential expression
of secretagogin immunostaining in the hippocampal formation and the
entorhinal and perirhinal cortices of humans, rats and mice. J. Comp. Neurol.
528, 523–541. doi: 10.1002/cne.24773
Tsaneva-Atanasova, K., Burgo, A., Galli, T., and Holcman, D. (2009).
Quantifying neurite growth mediated by interactions among secretory vesicles,
microtubules and actin networks. Biophys. J. 96, 840–857. doi: 10.1016/j.bpj.
2008.10.036
Van Genderen, H. O., Kenis, H., Hofstra, L., Narula, J., and
Reutelinsperger, C. P. M. (2008). Extracellular annexin A5: functions of
phosphatidylserine-binding and two-dimensional crystallisation. Biochim.
Biophys. Acta 1783, 953–963. doi: 10.1016/j.bbamcr.2008.01.030
Van Heerde, W. L., Poort, S., Van ’t Veer, C., Reutelinsperger, C. P. M., and De
Groot, P. G. (1994). Binding of recombinant annexin V to endothelial cells:
effect of annexin V binding on endothelial-cell-mediated thrombin formation.
Biochem. J. 302, 305–312. doi: 10.1042/bj3020305
Vogt, D., Hunt, R. F., Mandal, S., Sandberg, M., Silberberg, S. N., Nagasawa, T.,
et al. (2014). Lhx6 directly regulates Arx and CXCR7 to determine cortical
interneuron fate and laminar position. Neuron 82, 350–364. doi: 10.1016/j.
neuron.2014.02.030
Frontiers in Neuroanatomy | www.frontiersin.org 12 September 2020 | Volume 14 | Article 61
Alzu’bi and Clowry Secretagogin in Human Cortical Development
Wagner, L., Oliyarnyk, O., Gartner, W., Nowotny, P., Groeger, M., Kaserer, K.,
et al. (2000). Cloning and expression of secretagogin, a novel neuroendocrine-
and pancreatic islet of Langerhans-specific Ca2+-binding protein. J. Biol.
Chem. 275, 24740–24751. doi: 10.1074/jbc.m001974200
Wang, W. Z., Hoerder-Suabedissen, A., Oeschger, F. M., Bayatti, N.,
Ip, B. K., Lindsay, S., et al. (2010). Subplate in the developing cortex of
mouse and human. J. Anat. 217, 368–380. doi: 10.1111/j.1469-7580.2010.
01274.x
Yang, S. Y., Lee, J. J., Lee, J. H., Lee, K., Oh, S. H., Lim, Y. M., et al.
(2016). Secretagogin impacts insulin secretion in pancreatic β cells by
regulating actin dynamics and focal adhesion. Biochem. J. 473, 1791–1803.
doi: 10.1042/bcj20160137
Zecevic, N., and Rakic, P. (2001). Development of layer I neurons in the primate
cerebral cortex. J. Neurosci. 21, 5607–5619. doi: 10.1523/JNEUROSCI.21-15-
05607.2001
Zylbersztejn, K., and Galli, T. (2011). Vesicular traffic in cell
navigation. FEBS J. 278, 4497–4505. doi: 10.1111/j.1742-4658.2011.
08168.x
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Alzu’bi and Clowry. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Neuroanatomy | www.frontiersin.org 13 September 2020 | Volume 14 | Article 61
